房颤患者植入Watchman装置期间新型口服抗凝药与维生素K拮抗剂的比较：一个时代的终结。 - Suppr

Suppr

超能文献

NOACs versus VKAs during Watchman implantation in patients with atrial fibrillation: The end of an era.

作者信息

Romero Jorge, Briceño David F, Di Biase Luigi

机构信息

Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.

出版信息

Pacing Clin Electrophysiol. 2019 Oct;42(10):1310-1311. doi: 10.1111/pace.13797. Epub 2019 Sep 18.

DOI:10.1111/pace.13797

PMID:31483056

Abstract

摘要

相似文献

NOACs versus VKAs during Watchman implantation in patients with atrial fibrillation: The end of an era.

Pacing Clin Electrophysiol. 2019 Oct;42(10):1310-1311. doi: 10.1111/pace.13797. Epub 2019 Sep 18.

Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.

Clin Ther. 2017 Jul;39(7):1456-1478.e36. doi: 10.1016/j.clinthera.2017.05.358. Epub 2017 Jun 28.

Vitamin K and non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life.

Eur J Intern Med. 2016 Sep;33:42-6. doi: 10.1016/j.ejim.2016.06.022. Epub 2016 Jul 6.

Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta-analysis.

Cardiovasc Ther. 2018 Oct;36(5):e12457. doi: 10.1111/1755-5922.12457. Epub 2018 Jul 30.

Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.

Europace. 2016 Sep;18(9):1308-18. doi: 10.1093/europace/euw073. Epub 2016 Jun 21.

Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials.

Circulation. 2018 Mar 13;137(11):1117-1129. doi: 10.1161/CIRCULATIONAHA.117.028513. Epub 2017 Nov 3.

Differences in knowledge among patients with atrial fibrillation receiving non-vitamin K antagonist oral anticoagulants and vitamin K antagonists.

Kardiol Pol. 2018;76(7):1089-1096. doi: 10.5603/KP.a2018.0069. Epub 2018 Mar 12.

Economic evaluation of the use of non-vitamin K oral anticoagulants in patients with atrial fibrillation on antiplatelet therapy: a modelling analysis using the healthcare system in the Netherlands.

Eur Heart J Qual Care Clin Outcomes. 2019 Apr 1;5(2):127-135. doi: 10.1093/ehjqcco/qcy030.

Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation.

Am J Med. 2019 Jun;132(6):749-757.e5. doi: 10.1016/j.amjmed.2018.12.036. Epub 2019 Jan 19.

Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study.

BMJ Open. 2018 Jan 24;8(1):e019638. doi: 10.1136/bmjopen-2017-019638.

引用本文的文献

Detailed thrombogenicity phenotyping and 1 year outcomes in patients undergoing WATCHMAN implantation: (TARGET-WATCHMAN) a case-control study.

J Thromb Thrombolysis. 2020 Oct;50(3):484-498. doi: 10.1007/s11239-020-02205-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

NOACs versus VKAs during Watchman implantation in patients with atrial fibrillation: The end of an era.

作者信息

Romero Jorge, Briceño David F, Di Biase Luigi

机构信息

Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.

出版信息

Pacing Clin Electrophysiol. 2019 Oct;42(10):1310-1311. doi: 10.1111/pace.13797. Epub 2019 Sep 18.

DOI:10.1111/pace.13797

PMID:31483056

Abstract

摘要